174 related articles for article (PubMed ID: 37175205)
1. Functional Axis of PDE5/cGMP Mediates Timosaponin-AIII-Elicited Growth Suppression of Glioblastoma U87MG Cells.
Liao YF; Pan HJ; Abudurezeke N; Yuan CL; Yuan YL; Zhao SD; Zhang DD; Huang S
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175205
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.
Tinsley HN; Gary BD; Keeton AB; Lu W; Li Y; Piazza GA
Cancer Prev Res (Phila); 2011 Aug; 4(8):1275-84. PubMed ID: 21505183
[TBL] [Abstract][Full Text] [Related]
3. Timosaponin AIII: A novel potential anti-tumor compound from Anemarrhena asphodeloides.
Han FY; Song XY; Chen JJ; Yao GD; Song SJ
Steroids; 2018 Dec; 140():125-130. PubMed ID: 30296545
[TBL] [Abstract][Full Text] [Related]
4. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA
Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703
[TBL] [Abstract][Full Text] [Related]
5. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
Ren Y; Zheng J; Yao X; Weng G; Wu L
Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory mechanisms of timosaponin AⅢ on proliferation and growth of human glioblastoma cells].
Tan X; Pan HJ; Wu WD; Zhang DD
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1160-1166. PubMed ID: 29027433
[TBL] [Abstract][Full Text] [Related]
7. Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells.
Wang Y; Xu L; Lou LL; Song SJ; Yao GD; Ge MY; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Arch Pharm Res; 2017 Jan; 40(1):69-78. PubMed ID: 27271334
[TBL] [Abstract][Full Text] [Related]
8. Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.
Tinsley HN; Gary BD; Thaiparambil J; Li N; Lu W; Li Y; Maxuitenko YY; Keeton AB; Piazza GA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1303-13. PubMed ID: 20876730
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
Geng Y; Zhou L; Thompson WJ; Lotz M
J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling.
Gong Y; Xu CY; Wang JR; Hu XH; Hong D; Ji X; Shi W; Chen HX; Wang HB; Wu XM
Cell Death Dis; 2014 Nov; 5(11):e1544. PubMed ID: 25429621
[TBL] [Abstract][Full Text] [Related]
11. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
[TBL] [Abstract][Full Text] [Related]
12. How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme.
Sanati M; Aminyavari S; Mollazadeh H; Bibak B; Mohtashami E; Afshari AR
Pharmacol Rep; 2022 Apr; 74(2):323-339. PubMed ID: 35050491
[TBL] [Abstract][Full Text] [Related]
13. Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10.
Li N; Chen X; Zhu B; Ramírez-Alcántara V; Canzoneri JC; Lee K; Sigler S; Gary B; Li Y; Zhang W; Moyer MP; Salter EA; Wierzbicki A; Keeton AB; Piazza GA
Oncotarget; 2015 Sep; 6(29):27403-15. PubMed ID: 26299804
[TBL] [Abstract][Full Text] [Related]
14. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
Mullershausen F; Russwurm M; Koesling D; Friebe A
Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
[TBL] [Abstract][Full Text] [Related]
15. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
[TBL] [Abstract][Full Text] [Related]
16. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Zhu B; Vemavarapu L; Thompson WJ; Strada SJ
J Cell Biochem; 2005 Feb; 94(2):336-50. PubMed ID: 15526282
[TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells.
Zhu B; Strada S; Stevens T
Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L196-206. PubMed ID: 15792963
[TBL] [Abstract][Full Text] [Related]
19. Timosaponin AIII attenuates inflammatory injury in AGEs-induced osteoblast and alloxan-induced diabetic osteoporosis zebrafish by modulating the RAGE/MAPK signaling pathways.
Wang N; Xu P; Wang X; Yao W; Wang B; Wu Y; Shou D
Phytomedicine; 2020 May; 75():153247. PubMed ID: 32502823
[TBL] [Abstract][Full Text] [Related]
20. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
Jung O; Lee J; Lee YJ; Yun JM; Son YJ; Cho JY; Ryou C; Lee SY
Bioorg Med Chem Lett; 2016 Aug; 26(16):3963-7. PubMed ID: 27422337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
